Umpqua Bank Has $3.26 Million Holdings in Lam Research Co. (NASDAQ:LRCX)

Umpqua Bank boosted its holdings in shares of Lam Research Co. (NASDAQ:LRCX - Free Report) by 964.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 43,490 shares of the semiconductor company's stock after acquiring an additional 39,405 shares during the quarter. Lam Research comprises 1.1% of Umpqua Bank's holdings, making the stock its 18th largest holding. Umpqua Bank's holdings in Lam Research were worth $3,264,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in LRCX. Advisors Asset Management Inc. lifted its stake in Lam Research by 3.9% during the third quarter. Advisors Asset Management Inc. now owns 3,859 shares of the semiconductor company's stock worth $3,149,000 after purchasing an additional 144 shares during the last quarter. King Luther Capital Management Corp boosted its stake in shares of Lam Research by 17.9% during the 3rd quarter. King Luther Capital Management Corp now owns 15,345 shares of the semiconductor company's stock worth $12,523,000 after acquiring an additional 2,326 shares in the last quarter. Landscape Capital Management L.L.C. grew its holdings in Lam Research by 91.1% in the third quarter. Landscape Capital Management L.L.C. now owns 2,507 shares of the semiconductor company's stock valued at $2,046,000 after purchasing an additional 1,195 shares during the last quarter. Pacer Advisors Inc. increased its holdings in Lam Research by 9.2% during the 3rd quarter. Pacer Advisors Inc. now owns 24,366 shares of the semiconductor company's stock valued at $19,885,000 after acquiring an additional 2,062 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its stake in shares of Lam Research by 1.3% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 822,599 shares of the semiconductor company's stock worth $671,307,000 after purchasing an additional 10,868 shares in the last quarter. Hedge funds and other institutional investors own 84.61% of the company's stock.

Remove Ads

Lam Research Price Performance

Shares of NASDAQ:LRCX traded down $0.14 during midday trading on Tuesday, reaching $77.85. 2,308,770 shares of the company's stock were exchanged, compared to its average volume of 11,069,593. The firm has a market capitalization of $99.93 billion, a PE ratio of 23.67, a price-to-earnings-growth ratio of 1.47 and a beta of 1.53. The company's 50 day simple moving average is $79.70 and its two-hundred day simple moving average is $77.30. Lam Research Co. has a 12 month low of $68.87 and a 12 month high of $113.00. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.73 and a current ratio of 2.54.

Lam Research (NASDAQ:LRCX - Get Free Report) last announced its quarterly earnings results on Wednesday, January 29th. The semiconductor company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.87 by $0.04. Lam Research had a return on equity of 51.86% and a net margin of 26.49%. Equities research analysts expect that Lam Research Co. will post 3.71 earnings per share for the current fiscal year.

Lam Research Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 9th. Stockholders of record on Wednesday, March 5th will be paid a $0.23 dividend. This represents a $0.92 dividend on an annualized basis and a dividend yield of 1.18%. The ex-dividend date is Wednesday, March 5th. Lam Research's dividend payout ratio (DPR) is currently 27.96%.

Insider Transactions at Lam Research

In related news, SVP Seshasayee Varadarajan sold 110,080 shares of Lam Research stock in a transaction dated Thursday, February 20th. The stock was sold at an average price of $90.00, for a total value of $9,907,200.00. Following the completion of the transaction, the senior vice president now directly owns 179,084 shares of the company's stock, valued at $16,117,560. The trade was a 38.07 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 0.29% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the stock. Wolfe Research downgraded shares of Lam Research from an "outperform" rating to a "peer perform" rating in a research note on Wednesday, January 15th. Morgan Stanley upped their price objective on shares of Lam Research from $76.00 to $78.00 and gave the company an "equal weight" rating in a research report on Thursday, December 5th. Wells Fargo & Company lifted their target price on Lam Research from $82.00 to $85.00 and gave the stock an "equal weight" rating in a research report on Thursday, January 30th. Susquehanna raised Lam Research from a "neutral" rating to a "positive" rating and upped their target price for the company from $75.00 to $125.00 in a report on Thursday, February 20th. Finally, Sanford C. Bernstein upgraded Lam Research from a "market perform" rating to an "outperform" rating and boosted their price target for the stock from $85.00 to $91.00 in a research report on Thursday, January 30th. Six equities research analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $98.06.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.